Fluphenazine and Nortriptyline is a combination of two medications: Fluphenazine, a typical antipsychotic from the phenothiazine class, and Nortriptyline, a tricyclic antidepressant. This combination is used to manage psychotic disorders, particularly in patients with co-occurring depression and anxiety. The dual action targets both psychotic symptoms and mood disturbances.
The Fluphenazine and Nortriptyline combination is primarily used for:
| Brand Name | Flutrip |
|---|---|
| Type | Tablet |
| Weight | 0.5 mg+10 mg |
| Generic | Fluphenazine + Nortriptyline |
| Manufacturer | General Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Fluphenazine works by blocking dopamine (D2) receptors in the brain, reducing psychotic symptoms such as hallucinations and delusions. Nortriptyline, on the other hand, increases the levels of serotonin and norepinephrine by inhibiting their reuptake, improving mood and relieving depression.
The antipsychotic effects of Fluphenazine may take several days to weeks to manifest, while Nortriptyline's antidepressant effects may become noticeable after 2 to 4 weeks of treatment. Both drugs require consistent administration for optimal therapeutic effects.
Fluphenazine is well absorbed after oral or intramuscular administration, but its bioavailability varies due to extensive first-pass metabolism. Nortriptyline is also well absorbed orally, with peak plasma levels reached in 2 to 4 hours.
Fluphenazine is primarily metabolized by the liver and excreted in the urine. Nortriptyline is also metabolized by the liver, with its metabolites excreted through the urine.
Dosage of this combination depends on the patient’s condition and response:
This combination is available in oral form (tablets or liquid) and is typically taken once or twice daily, depending on the dosing schedule. Fluphenazine can also be administered via intramuscular injection for acute psychotic episodes.
Common side effects of Fluphenazine and Nortriptyline include:
Fluphenazine overdose may cause severe extrapyramidal symptoms, hypotension, and sedation, while Nortriptyline overdose can lead to cardiac arrhythmias, seizures, and coma. Both drugs can be toxic in high doses, requiring immediate medical attention.
Patients on this combination therapy should be closely monitored for:
This combination may interact with:
Fluphenazine and Nortriptyline should be used cautiously in patients with:
Major interactions include:
Patients should avoid alcohol while taking Fluphenazine and Nortriptyline as it may increase the sedative effects and impair cognitive function.
This combination should be used during pregnancy only if the potential benefits outweigh the risks. Both drugs may cause fetal harm, particularly in the third trimester. Babies born to mothers on Fluphenazine or Nortriptyline may experience withdrawal symptoms or extrapyramidal effects.
Both Fluphenazine and Nortriptyline are excreted in breast milk, and their use during lactation is generally not recommended. If necessary, breastfeeding mothers should consult their healthcare provider.
In cases of overdose, symptoms may include severe drowsiness, confusion, seizures, and cardiac arrhythmias. Immediate medical intervention, including gastric lavage and supportive care, may be required. Activated charcoal may be administered to reduce drug absorption.
Fluphenazine and Nortriptyline are contraindicated in patients with:
Patients should take the medication exactly as prescribed by their healthcare provider. Abrupt discontinuation should be avoided, as this may lead to withdrawal symptoms or exacerbation of psychiatric conditions. Dose adjustments may be necessary based on the patient’s response and side effects.
Store the medication at room temperature, away from moisture and heat. Keep the container tightly closed and out of the reach of children. Do not freeze the oral solution if applicable.
The volume of distribution for Fluphenazine is relatively large due to its lipophilic nature, allowing it to accumulate in fatty tissues. Nortriptyline also has a high volume of distribution, distributing widely into body tissues.
Fluphenazine has a half-life of about 15-30 hours, while Nortriptyline’s half-life ranges from 16-90 hours, depending on individual metabolism and patient-specific factors.
Both drugs are cleared primarily by hepatic metabolism. Their clearance rates may be reduced in patients with liver impairment, necessitating dose adjustments.
See in details version Flutrip Tablet 0.5 mg+10 mg also Flutrip Tablet 0.5 mg+10 mg in bangla
Prof. Dr. Md. Kamrul Ahsan
Orthopedics (Bone, Joint, Arthritis, Trauma) Specialist & Spine Surgeon